• 329 Citations
  • 8 h-Index
20062017

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Mahbuba Rahman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 329 Citations
  • 8 h-Index
  • 11 Article
  • 2 Chapter
  • 1 Comment/debate
  • 1 Review article

Inactivation of the kinase domain of CDK10 prevents tumor growth in a preclinical model of colorectal cancer, and is accompanied by downregulation of Bcl-2

Weiswald, L. B., Hasan, M. R., Wong, J. C. T., Pasiliao, C. C., Rahman, M., Ren, J., Yin, Y., Gusscott, S., Vacher, S., Weng, A. P., Kennecke, H. F., Bieche, I., Schaeffer, D. F., Yapp, D. T. & Tai, I. T., 1 Oct 2017, In : Molecular Cancer Therapeutics. 16, 10, p. 2292-2303 12 p.

Research output: Contribution to journalArticle

  • 4 Citations (Scopus)
  • 5 Citations (Scopus)

    Metabolic pathways and chemotherapy drugs

    Rahman, M., 1 Jan 2016, Frontiers in Drug Design and Discovery. 1 ed. Bentham Science Publishers B.V., p. 3-35 33 p. (Frontiers in Drug Design and Discovery; vol. 7, no. 1).

    Research output: Chapter in Book/Report/Conference proceedingChapter

  • Cancer metabolism and drug resistance

    Rahman, M. & Hasan, M. R., 30 Sep 2015, In : Metabolites. 5, 4, p. 571-600 30 p.

    Research output: Contribution to journalReview article

  • 63 Citations (Scopus)

    Correction: A peptide of SPARC interferes with the interaction between caspase8 and Bcl2 to resensitize chemoresistant tumors and enhance their regression in vivo

    Rahman, M., Chan, A. P. K., Tang, M. J. & Tai, I. T., 23 Apr 2015, In : PLoS One. 10, 4, e0127226.

    Research output: Contribution to journalComment/debate

  • 1 Citation (Scopus)